A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer 2

Author： McLeod D.   Zinner N.   Tomera K.   Gleason D.   Fotheringham N.   Campion M.   Garnick M.B.   for the Abarelix Study Group  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.58, Iss.5, 2001-11, pp. : 756-761

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists

By Koch M.   Steidle C.   Brosman S.   Centeno A.   Gaylis F.   Campion M.   Garnick M.B.   ABARELIX STUDY GROUP  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 877-882

Elsevier

Access to resources Recommend Favorite

Open-label phase II study of ZD0473 in patients with metastatic hormone-refractory prostate cancer

By Tyrrell C.   Bullard S.   Barber J.   Graham J.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 158-158

Elsevier

Access to resources Recommend Favorite

Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy for prostate cancer

By Incrocci L.   Hop W.C.J.   Slob A.K.  

Urology, Vol. 62, Iss. 1, 2003-07 ,pp. : 116-120

Elsevier

Access to resources Recommend Favorite

A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey)

By Shibasaki Toshiaki   Koyama Akio   Hishida Akira   Muso Eri   Osawa Gengo   Yamabe Hideaki   Shiiki Hideo   Makino Hirofumi   Sato Hiroshi   Ishikawa Isao   Maeda Kenji   Tomita Kimio   Arakawa Masaaki   Ishida Masashi   Sato Masashi   Nagase Mitsumasa   Kashihara Naoki   Yorioka Noriaki   Koike Takao   Saito Takao   Harada Takashi   Mitarai Tetsuya   Sugisaki Tetsuzo   Nagasawa Toshihiko   Tomino Yasuhiko   Nojima Yoshihisa   Kobayashi Yutaka   Sakai Osamu  

Clinical and Experimental Nephrology, Vol. 8, Iss. 2, 2004-06 ,pp. : 117-126

Springer Publishing Company

Access to resources Recommend Favorite

Combined hormono/chemotherapy as primary treatment for metastatic prostate cancer: a randomized, multicenter study of orchiectomy alone versus orchiectomy plus estramustine phosphate

By Janknegt R.A.   Boon T.A.   van de Beek C.   Grob P.  

Urology, Vol. 49, Iss. 3, 1997-05 ,pp. : 411-420

Elsevier

Access to resources Recommend Favorite